


nexion srl Email Formats
Biotechnology Research • Mirandola, Emilia-Romagna, Italy • 1-10 Employees
nexion srl Email Formats
nexion srl uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@nexion.ws), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@nexion.ws | 100% |
Key Contact at nexion srl
Paolo Galavotti
Owner, R&D
Company overview
| Headquarters | Via 2 Giugno 111, Mirandola, Modena 41037, IT |
| Founded | 2001 |
| Employees | 1-10 |
About nexion srl
field of activity: biotechnology, medical contact: paolo.galavotti@nexion.ws Paolo Galavotti is director of Nexion and has been working in the biomedical field since 1985. He has acquired technical and business experience in small and medium-sized companies and research centers, working on the design, development, and marketing of equipment for: manufacturing and testing disposable medical components and finished products for various applications (biomedical, biotech-pharma); electromedical machines for extracorporeal circulation to be used in intensive care; and machines and systems for the biotech-pharma sector. Nexion serves companies and research centers that work in the medical, biotech, and pharmaceutical sector, providing them with technical assistance in the research, design, development, and production of disposable products and medical devices, from the initial idea to the finished product. Nexion is located in Mirandola (Modena province), the largest biomedical cluster in Europe, which allows it to constantly monitor the technologies of the sector. Thanks to the knowledge and experience acquired in various fields of application (heart surgery, hemodialysis, hemofiltration, hemoconcentration, assisted fertilization, gynecology, infusion, obstetrics, transfusion, urology, and biotech-pharma), Nexion is able to work on specific projects.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
nexion srl has never raised funding before.
Frequently asked questions
4.8
40,000 users



